Document ID: chunk:federal_register_of_legislation:F2024L01734:schedule:1
Version: federal_register_of_legislation:F2024L01734
Segment Type: schedule
Provision Reference: sch 1
Character Range: 2480–3094

Schedule 1—Amendments

National Health (Commonwealth Price and Conditions for Commonwealth Payments for Supply of Pharmaceutical Benefits) Determination 2019 (PB 114 of 2019)

     1.            Schedule 1, after entry for Amoxicillin with clavulanic acid in the form Powder for oral suspension containing 125 mg amoxicillin (as trihydrate) with 31.25 mg clavulanic acid (as potassium clavulanate) per 5 mL, 75 mL
    insert:
Amoxicillin with clavulanic acid  Powder for oral suspension containing 125 mg amoxicillin (as trihydrate) with 31.25 mg clavulanic acid (as potassium clavulanate) per 5 mL, 100 mL (S19A)